Supporting Information · D # PCNA foci 40 80 100 120 0 20 60 C 0 10 20 30 40 50 60 # TUNEL...
Transcript of Supporting Information · D # PCNA foci 40 80 100 120 0 20 60 C 0 10 20 30 40 50 60 # TUNEL...
Supporting InformationMerlo et al. 10.1073/pnas.1419083111SI TextGenotypes.Fig. 1. ctr: elav-GAL4/+. p53 null: p5311-1B-1. tau: elav-GAL4/+;UAS-tauR406W/+. tau + p53 null: elav-GAL4/+;UAS-tauR406W,p5311-1B-1/p5311-1B-1.Fig. 4. tau: elav-GAL4/+;UAS-tauR406W/+. Clc-LOF: elav-GAL4/+;ClcDG23206/+ or elav-GAL4/+; UAS-tauR406W/ClcDG23206. Chc-1:(elav-GAL4/Chc1 or elav-GAL4/Chc1; UAS-tauR406W/+. Chc-4: elav-GAL4/Chc4 or elav-GAL4/Chc4; UAS-tauR406W/+. Rab26-OE: elav-GAL4/+; UAS-Rab26/+ or elav-GAL4/+; UAS-Rab26/+; UAS-tauR406W/+. UAS-Rab26-DN: elav-GAL4/+; UAS-Rab26T204N/+ orelav-GAL4/+; UAS-tauR406W/UAS-Rab26T204N. Rab26 RNAi: elav-GAL4/+; UAS-Rab26 RNAi 43730/+ or elav-GAL4/+; UAS-Rab26 RNAi 43730/+; UAS-tauR406W/+. Sytβ-LOF: elav-GAL4/+;SytβDG10711/+ or elav-GAL4/+; UAS-tauR406W/SytβDG10711. SytβRNAi: elav-GAL4/+; UAS-Sytβ RNAi JF02593 or elav-GAL4/+;UAS-tauR406W/UAS-Sytβ RNAi JF02593. Amph-LOF: elav-GAL4/+;AmphEY9339/+ or elav-GAL4/+; AmphEY9339/+; UAS-tauR406W/+.Amph RNAi: elav-GAL4/+; UAS-Amph RNAi 7190/+ or elav-GAL4/+; UAS-tauR406W/UAS-Amph RNAi 7190.Fig. S1. ctr: elav-GAL4/+. tau: elav-GAL4/+;UAS-tauR406W/+. tau +p5311-1B-1: elav-GAL4/+;UAS-tauR406W, p5311-1B-1/p5311-1B-1.p535A-1-4: p535A-1-4. tau + p535A-1-4: elav-GAL4/+; UAS-tauR406W,
p535A-1-4/p535A-1-4.Fig. S7. ctr – SCA3: elav-GAL4/+. ctr + SCA3: elav-GAL4/+;UAS-ATXN3-Q78/+. EGFP + SCA3: elav-GAL4/+; UAS-EGFP/+;UAS-ATXN3-Q78/+ . Amph-LOF + SCA3: elav-GAL4/+ ;AmphEY9339/+; UAS-ATXN3-Q78/+. Chc-LOF + SCA3: elav-GAL4/Chc1; UAS-ATXN3-Q78/+. Clc-LOF + SCA3: elav-GAL4/+; UAS-ClcDG23206/UAS-ATXN3-Q78. Sytβ RNAi + SCA3: elav-GAL4/+;UAS-Sytβ RNAi JF02593/UAS-ATXN3-Q78. Rab26-OE + SCA3:elav-GAL4/+; UAS-Rab26/+; UAS-ATXN3-Q78/+. Rab26-DN +SCA3: elav-GAL4/+; UAS-ATXN3-Q78/UAS-Rab26T204N.Fig. S8. ctr: elav-GAL4/+. p53 null: p5311-1B-1. tau: elav-GAL4/+;UAS-tauR406W/+. tau + p53 null: elav-GAL4/+;UAS-tauR406W,p5311-1B-1/p5311-1B-1.GFP-Atg8a: elav-GAL4/+; UAS-GFP-Atg8a/+. Tau + Atg8a:
elav-GAL4/+; UAS-tauR406W/ UAS-GFP-Atg8a. GFP-ref(2)P:elav-GAL4/+; UAS-GFP-ref(2)P/+. Tau + ref(2)P: elav-GAL4/+;UAS-tauR406W/UAS-GFP-ref(2)P.
Primers.ChIP primers for Drosophila p53 gene.
dp53 ChIP For 5′-CGCTTGTACTTGCATCATTCG-3′;dp53 ChIP Rev 5′-GCGCCTTGGCTGGATAAAC-3′;
3′ UTR ChIP For 5′-GTGGCAGCCGGTCGAA-3′;3′ UTR ChIP Rev 5′-CAGCCAAAGCGGATGCA-3′.
ChIP primers for Drosophila rpr gene.
rpr ChIP For 5′-CGGAAAACTGATATGGCGATAAG-3′;rpr ChIP Rev 5′-CGGTCCCTCAGTCTCCAAGTC-3′.
ChIP primers for validation of candidates in Drosophila.
Amph ChIP For 5′-ATGTTCAGCCACACAAGTACACGT-3′;Amph ChIP Rev 5′-ATGTACATTAAAAACAAGGTTCCGC-3′;Clc ChIP For 5′-TCTGCTGCCAGTGAAAAACG-3′;Clc ChIP Rev 5′-CAAGTTCACCGTGGCATCAT-3′;Chc #1 ChIP For 5′-AGAAAAGAGGCAGCATTATCATCA-3′;Chc #1 ChIP Rev 5′-CGCAACTCAACATGGCTGACT-3′;Chc #2 ChIP For 5′-GCTGGATTGTCCGAATTTGAC-3′;Chc #2 ChIP Rev 5′-GCAGGAATGCGGCAGACT-3′;Rab26 #1 ChIP For 5′-GGTGCAGAGTTACCGTGCTACA-3′;Rab26 #1 ChIP Rev 5′-GGTGTGCGACACGGCTACTT-3′;Rab26 #2 ChIP For 5′-CACGACGATGCTATCATGGC-3′;Rab26 #2 ChIP Rev 5′-ACGATAGCCAGGATATCCGGT-3′;Sytβ ChIP For 5′-CCTCGCTGGGCATGTGAT-3′;Sytβ ChIP Rev 5′-CCTTTGTGCCAAATTTAATTGTCA-3′.
ChIP primers for human BIN1.
hBIN1 prom For 5′-AGGGAATGGCCTGTGTGAAC-3′;hBIN1 prom Rev 5′-GAGAAATCGAGTCCCAGGAATG-3′;hBIN1 intron1 For 5′-GCACCCGGTCAGTTGTCTATC-3′;hBIN1 intron1 Rev 5′-GCAGCTGGCGTGATCCA-3′.
Solutions.RIPA buffer was composed of 10 mM Tris·Cl (pH 8.0),1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodiumdeoxycholate, 0.1% SDS, and 140 mM NaCl. NEEM buffer wasmade up of 10 mM Hepes pH 7.6, 1.5 mM MgCl2, 0.1 mMEDTA, 10 mM KCl, and 300 mM sucrose. NEB buffer was madeup of 0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Ac)2, 0.1 mMEDTA, and 10 mM Tris·HCl (pH 8).
Merlo et al. www.pnas.org/cgi/content/short/1419083111 1 of 7
D
# P
CN
A fo
ci
40
80
100
120
0
20
60
C
0
10
20
30
40
50
60
# T
UN
EL
posi
tive
cells
tau + p535A-1-4 p535A-1-4 tau +
p535A-1-4 p535A-1-4
PCNATUNEL
tau
ctr
A
ctr tau
TU
NE
L/P
CN
AD
AP
I
TUNEL PCNA
B
tau + p5311-1B-1
TUNEL PCNA
Fig. S1. p53 is neuroprotective in a Drosophila tauopathy model. (A) Loss of p53 (p5311-1B-1) in the brain increases tau-induced cell death, as indicated byTUNEL staining (Left) and cell-cycle activation and as monitored with PCNA expression (Right), arrows. (Scale bar: 20 μm.) (B) Colabeling of PCNA, TUNEL-positive neurons in tau-transgenic flies, arrows. (Scale bars: 5 μm.) (C) Apoptosis, indicated by the number of TUNEL-positive neurons, increases in the brains oftau-transgenic, p535A-1-4 animals. (D) Cell-cycle reactivation, indicated by the number of PCNA-positive foci, increases in the brains of tau-transgenic, p535A-1-4
animals. Flies are 10-d-old (n ≥ 6 per genotype). In the graph, values represent mean ± SEM. ctr, control: elav-GAL4/+.
02468
1012141618
rpr p53
IgGctrIrr
Fol
d en
richm
ent
Fig. S2. p53 antibody specifically immunoprecipitates p53 protein. ChIP assay showing that p53 binds regulatory regions of the p53 and rpr genes. Foldenrichment is expressed relative to IgG control. Values have been normalized to the total DNA and represent mean ± SEM. The graph is representative of oneof three independent triplicate assays. Chromatin for IP was taken from untreated (ctr) or irradiated (Irr) w1118 embryos.
Merlo et al. www.pnas.org/cgi/content/short/1419083111 2 of 7
−1
01
23
log2
rat
io−
10
12
3lo
g2 r
atio
8475000 8480000 8485000 8490000 8495000 8500000 8505000
−
+
Gen
e Galpha49BAmph
CG30055
ctr
tau
Amph
−1
01
23
log2
rat
io−
10
12
3lo
g2 r
atio
20230000 20235000 20240000 20245000
−
+
Gen
e
CG6951
CG17233
ctr
tau
Clc
Clc
Fig. S3. (Continued)
Merlo et al. www.pnas.org/cgi/content/short/1419083111 3 of 7
−10
12
3lo
g2 ra
tio−1
01
23
log2
ratio
−
+
Gen
e
ctr
tau−1
01
23
log2
ratio
−10
12
3lo
g2 ra
tio
−
+
Gen
e
ctr
tau
Rab26
15715000 15720000 15725000 15730000 15735000
Chc
Chc Aats-argCG32582
CG8565
21305000 21310000 21315000 2132000021325000 21330000 21335000
CG7338
CG7324Rab26
Fig. S3. (Continued)
Merlo et al. www.pnas.org/cgi/content/short/1419083111 4 of 7
−1
01
23
log2
rat
io−
10
12
3lo
g2 r
atio
−
+
Gen
e
ctr
tau
Sytb
15000000 15005000 15010000 15015000 15020000 15025000 15030000 15035000
CG11552CG32148
CG3020
Fig. S3. Representative high-resolution ChIP-chip analysis of p53 binding to the promoter regions of the Amph, Clc, Chc, Rab26, and Sytß genes. The log2 ratiofluorescence values for control flies (Top) and tau flies (Middle) chromatin hybridization is shown for a region of 30 kb. Gene positions in the genome (Bottom)are represented with rectangles (exons), connected by lines (introns). ctr, control: elav-GAL4/+.
Genomic sequence gene
cacaCAAAcactcgacatgctcacaagagcgcgc Amph
tgccccatcctttgtCATGccCTTGatcagtcaagtcaaChc
ccgagtcgatctggtCATGtccgtctgtccgtat
tagtccacaaggtcaCATGtcct
Rab26ctcccCTTGcctcgaccagtcat
ctacgatgaagtggaCATGcacccagccccgtcc
atggggctgtaatcaCATGcccaSytb
gcaaCAAGttgcgaaaaagcttt
Fig. S4. Genomic sequences of p53-responsive elements identified in synaptic gene promoters. Bold and uppercase characters indicate potential p53 consensus.
a-H3K4me3 taua-H3K4me3 ctrIgG
Fold
enr
ichm
ent (
A.U
.)
0
100
200
300
400
500
600
700
p53 Amph Chc Clc Rab26 Syt
Fig. S5. ChIP assay for H3K4me3 histone modification showing that the selected synaptic genes are actively transcribed. Fold enrichment is expressed relativeto negative control (IgG). Values have been normalized to the total DNA and represent mean ± SEM. The graph is representative of one of the three in-dependent triplicate assays. Flies are 10-d-old.
Merlo et al. www.pnas.org/cgi/content/short/1419083111 5 of 7
***
ClcDG23206
Chc-1 AmphEY9339
SytDG10711
Rab26T204N
UASRab26
- + - + - + - + - + - + - +
***
***
*** *** ***
wal
king
spe
ed (
cm /
30 s
ec)
tau
35
30
25
20
15
10
5
0
ctr
Fig. S6. Altering the function of synaptic genes in tau-transgenic animals modifies locomotion, measured as walking speed. Flies are 2-d-old (n = 18 flies pergenotype). In the graph, values represent mean ± SEM. Asterisks indicate significant differences compared with tau-transgenic flies by ANOVA with Student–Newman–Keuls post hoc test for multiple comparisons. ***P < 0.001. ctr, control: elav-GAL4/+.
+ + + + + + +EGFP LOF
Amph LOF Chc
LOFClc
RNAiSyt
OE DN Rab26
- +ctr
SCA3ctr
# K
enyo
n ne
uron
s
0
20
40
60
80
100
Fig. S7. Synaptic function modifiers do not alter neuronal toxicity of mutant ataxin 3. The number of Kenyon neurons per 250 μm2 was counted. Flies are10-d-old (n = 6 flies per genotype). In the graph, values represent mean ± SEM. ctr, control: elav-GAL4/+; SCA3, mutant ataxin 3: UAS-ATXN3-Q78.
Merlo et al. www.pnas.org/cgi/content/short/1419083111 6 of 7
B
Rel
ative
abu
ndan
ce (A
.U.)
0
0.2
0.4
0.6
0.8
1.0
ctr p53 null tau tau + p53 null
SynChaSyxdlg1
*
***
*
***
A
a-Cha
a-dlg1
tau tau + p53 null
p53 null
ctr
a-Syn
a-Syx
a-elav
a-actin
GF
PC
spC
sp/ G
FP
DA
PI
tau +GFP-Atg8aGFP-Atg8a tau +
GFP-ref(2)PGFP- ref(2)P
D
Ubi
quiti
nC
spC
sp/U
biqu
itin
DA
PI
taup53 null tau + p53 null
C
Fig. S8. Synaptic abnormalities in tau-transgenic animals. (A) There is a significant reduction in the expression of synaptic markers in the brains of tau-transgenic, p53-null flies. (B) Quantification of the protein expression reduction relative to control. In the graph, values represent mean ± SEM of at least threeWestern blots per antibody. Asterisks indicate significant differences compared with control flies by ANOVA with Bonferroni post hoc test for multiplecomparisons. *P < 0.05; ***P < 0.001. ctr, control: elav-GAL4/+. (C) Ubiquitin accumulates at synapses when tau is expressed in the absence of p53. (D) Au-tophagy markers accumulate at synapses in tau-transgenic flies. Flies are 10-d-old. (Scale bars: 10 μm.) Syn, Synapsin; Cha, Choline acetyltransferase; Syx,syntaxin; dlg1, discs large 1; Elav, embryonic lethal abnormal vision; Csp, Cysteine string protein; Atg8a, Autophagy-specific gene 8a, detected with a transgenicreporter (UAS-GFP-Atg8a) and anti-GFP immunofluorescence; ref(2)P, refractory to sigma P, also known as p62 and SQSTM1, detected with a transgenic re-porter (UAS-GFP-ref(2)P) and anti-GFP immunofluorescence.
Dataset S1. List of genes bound by p53 in tau-transgenic flies throughout the whole Drosophila genome
Dataset S1
Dataset S2. Gene Ontology analysis of the genes bound by p53 in tau-transgenic flies. To reduce the redundancy in gene setannotation, we used functional annotation clustering, which groups similar annotations together
Dataset S2
Dataset S3. Detailed list of the synaptic-transmission–related terms
Dataset S3
Merlo et al. www.pnas.org/cgi/content/short/1419083111 7 of 7